Nanologica AB (publ) (STO:NICA)
Sweden · Delayed Price · Currency is SEK 0.4690
+0.0170 (3.76%)
Aug 13, 2026, 5:16 PM CET
Nanologica AB Market Cap
Nanologica AB has a market cap or net worth of 154.19 million as of August 13, 2026. Its market cap has increased by 20.75% in one year.
Market Cap
154.19M
Enterprise Value
234.01M
Revenue
31.83M
Ranking
n/a
PE Ratio
1.80
Stock Price
0.47
ChartMarket Cap Chart
Since October 30, 2015, Nanologica AB's market cap has increased from 73.54M to 154.19M, an increase of 109.66%. That is a compound annual growth rate of 7.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 154.19M | 123.70% |
| Dec 30, 2025 | 68.93M | -57.14% |
| Dec 30, 2024 | 160.81M | -57.22% |
| Dec 29, 2023 | 375.92M | 33.47% |
| Dec 30, 2022 | 281.66M | -27.01% |
| Dec 30, 2021 | 385.87M | 3.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 200.28M |
| Elicera Therapeutics AB | 197.87M |
| Alzinova AB | 186.83M |
| Initiator Pharma | 173.19M |
| Abera Bioscience AB | 166.45M |
| Diamyd Medical AB | 160.25M |
| Xintela AB | 155.89M |
| Biovica International AB | 153.55M |